Enhancement Effect of Berberis vulgaris var. integerrima Seeds on the Antibacterial Activity of Cephalosporins against Staphylococcus aureus and Escherichia coli Synergistic effect of Berberis vulgaris and cephalosporins
Iranian Journal of Pharmaceutical Sciences,
Vol. 3 No. 3 (2007),
1 July 2007
,
Page 181-186
https://doi.org/10.22037/ijps.v3.41018
Abstract
To evaluate the enhancement effect of Berberis vulgaris var. integerrima seeds on the antibacterial activity of cephalexin and ceftizoxime against Staphylococcus aureus and Escherichia coli ethanol extract of the seeds were prepared. Disk diffusion and broth dilution methods were used to determine the antibacterial activity of two cephalosporins in the absence and presence of the extract and its various fractions separated by thin layer chromatography. Clinical isolates of S. aureus and E. coli were used as test strains. Total extract and one of its fractions enhanced the antibacterial activity of cephalexin and ceftizoxime. The active component of the extract involved in the enhancement of cephalexin and ceftizoxime antimicrobial activities had an Rf of 0.47 on TLC and a lmax of 209 nm. The highest fold decrease
in minimum inhibitory concentration was observed for ceftizoxime plus the active fraction of the extract against E. coli. Our preliminary results on the column chromatography and identification of the active component by high resolution mass spectroscopy showed that this minor compound may be categorized as a protoberberine structure compound. Therefore, the ethanolic extract of B. vulgaris
var. integerrima seeds combined with cephalosporins may be useful against S.aureus and E. coli.
- Antibacterial activity
- Berberis vulgaris
- Ceftizoxime
- Cephalexin
- Staphylococcus aureus
How to Cite
References
[2] Schito GC. The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect 2006; 12 (Supplement 1):3-8.
[3] Wright GD. Bacterial resistance to antibiotics: Enzymatic degradation and modification. Adv Drug Deliver Rev 2005; 57: 1451- 70.
[4] Renau TE, Hecker SJ, Lee VJ. Antimicrobial potentiation approaches: Targets and inhibitors. Ann Rep Med Chem 1998; 33:121-30.
[5] Wright GD. Resisting resistance: New chemical strategies for battling superbugs. Chem Biol 2000; 7: R127-32.
[6] Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999; 12: 564-82.
[7] Liu LX, Durham DG, Richards RME. Vancomycin resistance reversal in entrococci by flavonods. J of Pharm Pharmacol 2001; 53:129-32.
[8] Oumzil H, Ghoulami S, Rhajaoui M, Ilidrissi A,Fkih-Tetouani S, Faid M, Benjouad A.Antibacterial and antifungal activity of essential oils of Mentha suaveolens. Phytother Res 2002; 16: 727-31.
[9] Markham PN, Neyfakh AA. Inhibition of the multi-drug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob Agents Ch 1996; 40: 2673-4.
[10] Shahverdi AR, Rafii F, Tavassoli F, Bagheri M, Attar F, Ghahraman A. Piperitone from Mentha longifolia var. chorodictya Rech F. reduces the nitrofurantoin resistance of strains of enterobacteriaceae.
Phytother Res 2004; 18P: 911-4.
[11] National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard 5th ed. NCCLS document M7-A5. Wayne, 2000.
[12] Shin S, Pyun M-S. Anti Candida effect of estragole in combination with ketaconazole or amphotericin B. Phytother Res 2004; 18: 827-30.
[13] Gibbons, S. Plants as a source of bacterial resistance modulators and anti-infective agents. Phytochem Rev 2005; 4: 63-78.
- Abstract Viewed: 296 times
- IJPS_Volume 3_Issue 3_Pages 181-186 Downloaded: 169 times